Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.
about
Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongationTelomeres in aging and disease: lessons from zebrafishTissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaTelomeres, NAFLD and Chronic Liver DiseaseAlternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progressionShort Telomeres in Key Tissues Initiate Local and Systemic Aging in ZebrafishAutocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 ExpressionMolecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinomaHepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapiesTelomere dysfunction induces metabolic and mitochondrial compromise.Cause-specific telomere factors deregulation in hepatocellular carcinoma.Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplicationMolecular mechanisms underlying hepatocellular carcinomaTransient telomere dysfunction induces chromosomal instability and promotes carcinogenesis.Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United StatesChronic hepatitis B in hepatocarcinogenesisMolecular approaches to treatment of hepatocellular carcinoma.Molecular targeted therapies in hepatocellular carcinomaHigh frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesionsTelomere dysfunction and tumour suppression: the senescence connectionGenetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis.Identification of tumor evolution patterns by means of inductive logic programming.Extracting extra-telomeric phenotypes from telomerase mouse models.Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice.Molecular events in hepatic preneoplasia: a review.Telomere and telomerase in chronic liver disease and hepatocarcinoma.NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinomaTelomeres: Implications for Cancer Development.Molecular Targets in Hepatocarcinogenesis and Implications for Therapy
P2860
Q24310189-A9A6963E-A566-4929-90AD-87C509DDFBCDQ26740023-61691EA6-460F-4673-AA9A-AAA56BA8CB87Q26743361-47BE1CC5-E7BF-400D-9EC6-4B01AB554F5DQ26753037-E8225BC1-338F-4E38-80AE-3CEF8960ADCDQ26862886-84BD8CC8-F539-4A79-9A15-1FC34E0DC445Q28272305-8EB22467-A652-4E73-BC78-25A722FF3C20Q33838977-5E089F6C-9933-497B-9922-831F63917DB7Q33855801-C07C9BF3-4695-446B-AFE6-4C3030C81034Q33866121-F5C01441-8B9C-411B-804B-7675A84CC167Q33895113-94347870-0C1F-47B9-BA72-551EB8E198E3Q34163637-0DB934F7-28F6-428A-BB39-657ED2DBF2F9Q34982993-8ED43A46-D3F1-4ECF-B1D9-2BF60B50A97AQ35052589-429869C9-A9D0-4503-A5EF-AB9CF49D0C62Q35260040-64360603-6725-48C6-A393-C1DB5F30FCEDQ36005397-80B05FFE-0B4C-4289-848E-43FC5529BF96Q36144711-94519D04-838B-438C-8F9E-A61C0AF9CEDAQ36167647-39F86664-7A41-4EB3-B66B-C2ADE8EB5BB1Q36202481-E810A3AF-2C17-4269-9561-482B16DFD573Q36557635-770C2AA8-9C50-41D0-8482-F54EBF77D1A4Q36955912-E74FD5D3-AE71-4EAB-A1D3-4BEC160568EFQ37003665-FC3FB1D7-16A4-4323-B2B5-D9B21B2F6D49Q37064910-6D908BEB-FAFA-424C-9869-E781B2ACAB05Q37171810-0A895C93-B3EF-42B9-A560-39170BE83F77Q37245378-FC9225CC-8C51-4456-8C32-6B3D5EA9BD57Q37318341-D1763A92-0300-4B26-88B9-833C3474A9FBQ37418806-A7602B9A-2D88-43BE-AAE0-33F4486A9FCEQ37646957-1417A035-7977-4C38-8792-864873748054Q37680387-DD2066A5-65B3-4A57-85FD-12F46DDC50D9Q38216014-1124210D-5C10-41BA-9D4E-1D8CD6B016D7Q39976770-0E03E095-19AE-4813-8916-8519E22C678FQ48207441-30E875D3-E34A-4C9F-A507-CD5D23CB843FQ58784853-7D1FA846-D540-49FB-9216-79FFDF6406C6
P2860
Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Differential impact of telomer ...... n of hepatocellular carcinoma.
@en
Differential impact of telomer ...... n of hepatocellular carcinoma.
@nl
type
label
Differential impact of telomer ...... n of hepatocellular carcinoma.
@en
Differential impact of telomer ...... n of hepatocellular carcinoma.
@nl
prefLabel
Differential impact of telomer ...... n of hepatocellular carcinoma.
@en
Differential impact of telomer ...... n of hepatocellular carcinoma.
@nl
P2093
P1433
P1476
Differential impact of telomer ...... on of hepatocellular carcinoma
@en
P2093
Jonathan Glickman
Paraskevi A Farazi
Ronald A DePinho
Shan Jiang
P304
P407
P577
2003-08-01T00:00:00Z